SalvaRx Group PLC (LSE:SALV) - Overview

Stock Report

SalvaRx Group PLC SALV

Last Price
GBX32.00

Day Change
0.00|0.00%

As of 02/12/2016
15:41:00 GMT | GBX
Minimum 15 Minutes Delay.

Last Close32.00p
Day Range31.65 - 31.69
Mkt Cap11.67Mil
52-Wk Range22.25 - 37.00
Yield %0.00
ISINIM00BZ4SS228
Volume2,915
P/E-8.00
P/SInfinity
P/CF-5.41

Share Price

Total Returns 02/12/2016

 Chg (%)  
More ...
SalvaRx Group PLC3.23 
FTSE 100 TR GBP-1.21
 
Financials
201320142015
More ...
Income Statement
Turnover0.000.000.00
Operating Profit0.000.00-0.19
Net Profit0.000.00-0.19
Reported EPS0.000.00-4.00
Balance Sheet
Current Assets27.121.441.00
Non Current Assets25.870.000.22
Total Assets52.991.441.22
Current Liabilities0.420.140.12
Total Liabilities0.420.140.12
Total Equity52.561.291.10
Cash Flow
Operating Cash Flow-2.78-1.49-0.30
Net Change in Cash-12.53-25.42-0.43
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------

Company Profile

SalvaRx Group PLC is a drug discovery and development company focused on immune-oncology. It invests in cancer immuno-therapies and provides its portfolio companies with operational support.
 

Sector

Biotechnology

Market Position

1473 of 1865 Companies

Index

FTSE AIM All Share

Outlook

(13/09/2016) no outlook statement

Next Event 31/12/2016

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)0.0013.1416.27
Div Yld (E)0.004.184.36
PEG (E)0.000.360.00
ROCE-17.52206.9680.66
Op Mrgn0.00-17.09-14.86
EPS Grwth0.009.6525.03
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanJim Mellon
Chief Executive OfficerDr. Ian Walters
Chief Financial OfficerKam Shah
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.